David G. DeNardo
Research Interests
Explore related searches
Contact this professor
Get a free first email built on one of their papers, ready for you to edit and send yourself.
Articles (13)
Year:
2024
Year:
2024
Summary PD1-blockade combinations in pancreatic ductal adenocarcinoma have been poorly effective, and the underlying reasons for this are unknown. A recent study revealed that chemoradiation plus PD1-blockade reinvigorates tumor-specific T cells; however, this T-cell activation is accompanied with exaggerated NFκB signaling, which may limit productive tumor-controlling immunity. See related article by Ali et al., p. 542
Year:
2023
Year:
2021
Year:
2021
Year:
2021
Year:
2020
Year:
2020
Year:
2020
Year:
2020
Year:
2020
Year:
2020
Year:
2020
Collaborators (17)
Sung Hoon Cho
Research assistant professor
Vanderbilt University Medical Center
Carl DeSelm
Assistant Professor
Washington University in St. Louis
Ashley Laughney
Assistant Professor
Weill Cornell Medicine
Anna Vilgelm
Assistant Professor
Ohio State University
Scott Powers
Professor
Stony Brook University
Sunil Hingorani
Fred Hutchinson Cancer Research Center
Siyuan Zhang
Associate Professor
University of Texas Southwestern Medical Center
Deanna Edwards
Research Assistant Professor
Vanderbilt University Medical Center
Igor Astsaturov
Associate Professor
Fox Chase Cancer Center
Wenbao Yu
Research Assistant Professor
University of Pennsylvania
Siri Strand
Assistant professor
Aarhus Universitetshospital
Qingfei Wang
Indiana University School of Medicine
Hao Wu
Assistant Professor
University of Pennsylvania
James Alexander Nathan
Wellcome Senior Clinical Research Fellow, Professor of Respiratory Medicine, Honorary Consultant Physician
University of Cambridge
Samuel Lee
University of North Carolina, Lineberger Comprehensive Cancer Center
Erik Sahai
The Francis Crick Institute
Damir Sudar
Chief Science Officer
-
Make your next move.
Prepare your application
Review drafts before you send them.